Showing results (161-170 of 174) with videos related to
Sort By:
Pageof 18
Journal for Immunotherapy of Cancer|March 28, 2025
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myelomaChunxiang Jin, Rongrong Chen, Shan Fu, et al.Contemporary Clinical Trials|March 4, 2021
A 3-armed multicenter randomized controlled trial: Placental Transfusion in Very Preterm Infants (PT-VPI)Guang Yue, Yan Wu, Fangping Zhao, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2020
Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell LeukemiaXue Li, Xin Guo, Yuqing Zhu, et al.Journal of Advanced Research|February 13, 2025
Sequential allogeneic HSCT after CAR-T therapy for relapsed/refractory acute lymphoblastic leukemia patients: A long-term follow-up resultTingting Yang, Yetian Dong, Jimin Shi, et al.British Journal of Haematology|May 16, 2023
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre studyLinghui Zhou, Weijun Fu, Shenghao Wu, et al.JAMA Oncology|April 17, 2025
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical TrialMingming Zhang, Shan Fu, Jingjing Feng, et al.JAMA Oncology|July 23, 2026
Ultralow-Dose Interleukin 10-Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Nonrandomized Clinical TrialYongxian Hu, Mingming Zhang, Min Gao, et al.Bone Marrow Transplantation|December 3, 2024
Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?Bingqian Jiang, Tingting Yang, Yanmin Zhao, et al.Cell Research|September 23, 2022
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical studyYongxian Hu, Yali Zhou, Mingming Zhang, et al.The New England Journal of Medicine|April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD ProphylaxisYongxian Hu, Mingming Zhang, Tingting Yang, et al.Pageof 18